克拉迪维护正常的中枢神经系统细胞活动,并促进神经保护氧化应激损伤
Herena Eixarch1,2, Laura Calvo-Barreiro1,2, Nicolás Fissolo1,2,3
1Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
International journal of molecular sciences
|December 11, 2025
概括
克拉迪宾是一种口服多发性硬化症 (MS) 治疗方法,它不会损害中枢神经系统 (CNS) 的细胞质,但可能会保护神经元免受氧化应激. 这项研究研究了克拉德里宾.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 是一种慢性神经炎症疾病,影响中枢神经系统功能.
- 克拉迪宾是治疗复发性多发性硬化症的口服治疗剂,已知会耗尽淋巴细胞.
- 克拉德里宾的血脑屏障透表明对中枢神经系统居民细胞的潜在影响.
研究的目的:
- 为了研究cladribine在治疗度下对人类中枢神经系统 (CNS) 居民细胞的影响.
- 确定克拉迪宾对质细胞和神经细胞活力,增殖,细胞因子产生和氧化应激反应的影响.
主要方法:
- 使用的人类原始细胞和人体细胞系,包括微质细胞 (HMC3),星球细胞,神经元原生细胞和神经母细胞瘤 (SH-SY5Y) 细胞.
- 暴露于不同治疗度的克拉迪宾的细胞.
- 评估了细胞存活,增殖,细胞因子生产,活性氧物种 (ROS) 生成和对氧化应激的反应.
主要成果:
- 克拉迪宾并没有对人类微质细胞或星球细胞的存活,增殖或细胞因子产生产生不利影响.
- 克拉迪宾增强了微质细胞和天体细胞类型中的活性氧物种的产生.
- 虽然高度的克拉迪因暂时损害了神经元前代细胞的分化,但它保护了分化的神经元细胞免受氧化应激诱导的死亡.
结论:
- 克拉迪似乎维持了中枢神经系统的正常功能.
- 克拉德里宾对神经元细胞产生保护作用,防止氧化应激损伤.
- 这些体外发现表明,在中枢神经系统的背景下,除了淋巴细胞枯竭之外,cladribine可能具有有益的作用.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
512
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
512
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
The Blood-brain Barrier
52.1K
Overview
52.1K
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K


